These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17290341)

  • 21. A case of severe early-onset OHSS after GnRH-agonist triggering.
    Kol S
    Fertil Steril; 2011 Sep; 96(3):e151; author reply e152. PubMed ID: 21763648
    [No Abstract]   [Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy?
    Partridge AH
    J Clin Oncol; 2012 Feb; 30(5):479-81. PubMed ID: 22231046
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.
    Shore ND; Sieber P; Schimke L; Perzin A; Olsen S
    Urol Nurs; 2013; 33(5):236-44, 248. PubMed ID: 24354113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the efficiency of gonadotrope releasing hormone (GnRH) analogs for the treatment of endometriosis].
    Keresztúri A; Daru J; Pál A
    Orv Hetil; 2002 Jun; 143(24):1475-8. PubMed ID: 12138645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptorelin in the management of prostate cancer.
    Ploussard G; Mongiat-Artus P
    Future Oncol; 2013 Jan; 9(1):93-102. PubMed ID: 23252566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-tumor effects of GnRH analogs in gynecological cancers].
    Yano T; Taketani Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():127-31. PubMed ID: 16689297
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment.
    Gül Ü; Kaçar Bayram A; Kendirci M; Hatipoğlu N; Okdemir D; Gümüş H; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):365-7. PubMed ID: 27087351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cryohormonal treatment of patients with intrauterine endometriosis].
    Tumasian KP; Bespoiasnaia VV; Voronovskaia IV
    Lik Sprava; 2001; (1):86-7. PubMed ID: 15311703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential pharmacological treatment of paraphilias and sex offenders.
    Hill A; Briken P; Kraus C; Strohm K; Berner W
    Int J Offender Ther Comp Criminol; 2003 Aug; 47(4):407-21. PubMed ID: 12971182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Catemenial pneumotorax: recurrence after first dose of gonadotropin-releasing hormone (GnRH) analogues].
    Suárez E; Vila E; Canela M; Xercavins J
    Med Clin (Barc); 2005 Mar; 124(9):358-9. PubMed ID: 15760609
    [No Abstract]   [Full Text] [Related]  

  • 34. Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment.
    Tsavaris N; Kopterides P; Kosmas C; Siakantaris M; Patsouris E; Pangalis G
    Leuk Lymphoma; 2006 Mar; 47(3):557-60. PubMed ID: 16396781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.
    Orvieto R; Homburg R; Meltcer S; Rabinson J; Anteby EY; Scharf S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1378-80. PubMed ID: 18675972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INN Common stem: -relin.
    Prescrire Int; 2017 Jan; 26(178):12. PubMed ID: 30730635
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ; Wei LH; Li XP; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
    Lee MM
    N Engl J Med; 2003 Mar; 348(10):942-5. PubMed ID: 12621139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.